[Ip-health] Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIHFunding in Key Gleevec Patent | Bill of Health

Ophira Ginsburg ophiraginsburg at gmail.com
Fri Oct 11 11:32:10 PDT 2019


Wow! Congratulations Jamie!

Sent from my iPhone

> On Oct 11, 2019, at 12:58 PM, Joseph Fortunak <jfortunak at comcast.net> wrote:
> 
> CONGRATULATIONS JAMIE, well done indeed!!
> 
> Sent from Mail for Windows 10
> 
> From: James Love
> Sent: Friday, October 11, 2019 12:09 PM
> To: Ip-health
> Subject: [Ip-health] Novartis, Dana Farber,Oregon Health & Science University Wait 18 Years to Disclose NIHFunding in Key Gleevec Patent | Bill of Health
> 
> After 18 years, Novartis gets around to disclosing NIH funding in a Gleevec
> patent.
> 
> Jamie
> 
> 
> http://blog.petrieflom.law.harvard.edu/2019/10/11/novartis-dana-farber-oregon-health-science-university-wait-18-years-to-disclose-nih-funding-in-key-gleevec-patent/
> 
> This is a story about U.S. patent number 6,958,335, and how it took more
> than 18 years for Novartis to acknowledge National Institutes of Health
> (NIH) funding in a key patent for Gleevec, allowing Novartis to shape the
> narrative regarding its role in the development of Gleevec, and also to
> avoid demands that Novartis make the invention “available to the public on
> reasonable terms,” which is an obligation under the Bayh-Dole Act.
> ....
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
> 
> 
> 
> -- 
> This email has been checked for viruses by Avast antivirus software.
> https://www.avast.com/antivirus
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org



More information about the Ip-health mailing list